Preprinted risk assessment and prophylaxis order form for venous thromboembolism

American Journal of Health-System Pharmacy

Volumn 64, Issue 12, 2007, Pages 1294-1298

  Elsasser, Gary N ^a   Goodman, Mark D ^b   Destache, Christopher J ^c   Frey, Donald R ^b   Hadi, Zack ^d  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^b Temple University School of Medicine   (United States)

^c Department of Pharmacy Practice and Family Medicine   (United States)

^d CUMC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; DRUG DERIVATIVE; ITF 300; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; DECISION MAKING; EMBOLISM PREVENTION; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ORDER; MEDICAL RECORD; PRACTICE GUIDELINE; PRINTING; PRIORITY JOURNAL; RISK ASSESSMENT; RISK ASSESSMENT AND PROPHYLAXIS ORDER FORM; THROMBOSIS PREVENTION; UNITED STATES; VENOUS THROMBOEMBOLISM; CASE CONTROL STUDY; COMPARATIVE STUDY; HOSPITAL INFORMATION SYSTEM; MIDDLE AGED; RETROSPECTIVE STUDY; THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HEPARIN; HUMANS; MALE; MEDICAL ORDER ENTRY SYSTEMS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; THROMBOEMBOLISM;

EID: 34547647046     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060235     Document Type: Article

References (13)

1. Anderson FA Jr, Wheeler HB, Goldberg RJ et al. A population-based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT study. Arch Intern Med. 1991; 151:933-8.
2. Alikhan R, Peters F, Wilmott R et al. Fatal pulmonary embolism in hospitalized patients; a necropsy review. J Clin Pathol. 2004; 57:1254-7.
3. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999; 353:1386-9.
4. Caprini JA, Botteman MF, Stephens JM et al. Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value Health. 2003; 6:59-74.
5. Geerts WH, Pineo GF, Heit JA et al. Prevention of venous thromboembolism. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004; 126:338S-400S.
6. Halkin H, Goldberg J, Modan M et al. Reduction of mortality in general medicine in-patients by low dose heparin prophylaxis. Ann Intern Med. 1982; 96:561-5.
7. Samama MM, Cohen AT, Darmon JY et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group (MEDENOX). N Engl J Med. 1999; 341:793-800.
8. Geerts WH, Heit JA, Clagett GP et al. Prevention of venous thromboembolism. The sixth ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2001; 119:132S-75S.
9. Stark JE, Kilzer WJ. Venous thromboembolic prophylaxis in hospitalized medical patients. Ann Pharmacother. 2004; 38:36-40.
10. Arnold DM, Kahn SR, Shrier I. Missed opportunities for prevention of venous thromboembolism: an evaluation for the use of thromboprophylaxis guidelines. Chest. 2001; 120:1964-71.
11. Leizorovovicz A, Mismetti P. Preventing venous thromboembolism in medical patients. Circulation. 2004; 110(suppl IV):IV13-9.
12. National Quality Forum. National consensus standards for the prevention and care of venous thromboembolism (including deep vein thrombosis and pulmonary embolism). www.qualityforum.org/projects/ongoing/vte/index.asp (accessed 2007 Mar 7).
13. Agency for Healthcare Research and Quality. 30 Safe practices for better health care. www.ahrq.gov/qual/30safe.pdf (accessed 2007 Mar 7).